We are live on ! Find out more

State Street Health Care Select Sector SPDR ETF

XLV

Market cap $44.6B

171.58 USD

-1.96

1.13%

At close Updated Aug 27, 4:00 PM EDT

Pre-market

After hours

171.45

-0.13

0.08%

1 day

-1.13%

5 days

-0.19%

1 month

5.01%

3 months

15.32%

6 months

7.1%

Year to date

10.33%

1 year

25.27%

5 years

27.45%

10 years

134.3%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 55.9%

Neutral 33.8%

Negative 10.3%

Zacks Investment Research

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

Zacks Investment Research

Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?

If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the State Street Health Care Select Sector SPDR ETF ETF (XLV), a passively managed exchange traded fund launched on December 16, 1998.

Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?

CNBC Television

Emily Field: Large pharma companies are going to continue looking at biotech

Emily Field, Head of U.S. Biopharma Equity Research at Barclays, says biotech is gaining momentum as M&A returns, capital markets reopen and breakthroughs in cancer vaccines fuel investor interest.

Emily Field: Large pharma companies are going to continue looking at biotech

Healthcare Is Rising: XLV Is A Better Option For Investors Than BME

BlackRock Health Sciences Trust (BME) has recently outperformed due to a narrowing NAV discount, not superior portfolio management. XLV, the passive healthcare ETF, has consistently delivered higher total returns and better NAV preservation than BME over 5- and 10-year periods. BME's recent strategy shift away from call options to capital gains distributions has not produced positive alpha relative to XLV.

Healthcare Is Rising: XLV Is A Better Option For Investors Than BME

The Big 3: XLV, ARM, NKE

Don Kaufman (@Theotrade) sees two strong bearish opportunities and one "shot" to the upside on Wednesday's Big 3. He sees a likely pullback in the State Street Health Care Sector SPDR ETF (XLV) amidst Moderna's (MRNA) stellar rally.

The Big 3: XLV, ARM, NKE

Zacks Investment Research

Healthcare ETFs Are Looking Up: Here's Why

Healthcare ETFs are hitting 52-week highs as earnings improve, dealmaking accelerates, FDA approvals stay strong and investors seek defensive growth.

Healthcare ETFs Are Looking Up: Here's Why

CNBC Television

Healthcare sector looks to be a beneficiary of the turbulence in tech: Renaissance Macro's deGraaf

Jeff deGraaf, Renaissance Macro chairman, joins 'Closing Bell' to discuss the technical indicators moving equity markets, the healthcare sector and much more.

Healthcare sector looks to be a beneficiary of the turbulence in tech: Renaissance Macro's deGraaf

Zacks Investment Research

Likely ETF & Stock Winners From July Jobs Report

Weak July jobs data raises hopes for Fed easing, putting health care and select retail ETFs and stocks in focus.

Likely ETF & Stock Winners From July Jobs Report

Healthcare Investing Is Now an AI Short in Disguise

Big healthcare companies are increasingly trading opposite to tech.

Healthcare Investing Is Now an AI Short in Disguise

Sector ETFs Post Record $25B Inflow as Tech Leads

U.S.-listed sector ETFs pulled in a record $25 billion in July, according to a report from State Street Investment Management. Investors used a sharp technology selloff to load up on artificial intelligence-related stocks at lower prices.

Sector ETFs Post Record $25B Inflow as Tech Leads

See News Rankings

Price charts implemented using Lightweight Charts™